Despite limitations, hypertension status did not appear to strongly influence RAS gene expression; however, ACE2 gene expression was higher in the >85-year-old group, and in the AD group, for those hypertensive patients prescribed RAS-targeting drugs. Here, ACE2 is linked to Alzheimer disease.